Presbyopia awareness: A deep dive with Brieann Adair, OD

Video

Presbyopia awareness: Causes, risk factors, symptoms, correction options and market trends.

In celebration of Presbyopia Awareness Month, Brieann K. Adair, OD, of NYU Langone Health, speaks with Optometry Times' Sheryl Stevenson about the importance of Presbyopia awareness, causes of the condition, risk factors, symptoms, correction options and market trends.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Subscribe Now!
Recent Videos
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
OptiLIFT in action: Dr. Julie McLaughlin's experience with the new device
Dr. Mile Brujic discusses a case series on a novel gel for lacrimal occlusion.
What was the biggest innovation in eye care in 2024?
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Billy R. Hammond details the study, which explored how HEV-light filtering, specifically in the 380-440 nanometer range, impacts visual comfort for patients with presbyopia.
Kurt Moody, OD, FAAO, describes how to fit multifocal contact lenses in a way that patients love
Bonnie An Henderson, MD, highlights key takeaways of the 2024 EnVision Summit, including diversity and family inclusion
Jacob R. Lang, OD, FAAO
Jeffrey J. Walline, OD, PhD
Related Content
Atropine 0.05% receives CDSCO approval in India for myopia management. - Image credit:©vitalis83 – stock.adobe.com

ENTOD Pharmaceuticals announces CDSCO approval of 0.05% atropine drops in India

Hattie Hayes;Emily Kaiser Maharjan, Assistant Managing Editor;Jordana Joy, Associate Editor
April 23rd 2025
Article
Practical management EP 14: Your practice-purchase checklist

Practical management EP 14: Your practice-purchase checklist

Maria Sampalis, OD;Kassi Filkins, Editor
April 27th 2023
Podcast
FDA grants 510(k) clearance to BVI Medical for laser endoscopic surgical system for glaucoma - Image credit: Adobe Stock / ©monticellllo

BVI Medical receives 510(k) clearance FDA for laser endoscopic surgical system for glaucoma

Sydney M Crago, Editor, Modern Retina;Emily Kaiser Maharjan, Assistant Managing Editor
April 17th 2025
Article
Jill Saxon, OD, executive director of professional strategy at Bausch + Lomb

Community care: Connecting mentorship and representation

Emily Kaiser Maharjan, Assistant Managing Editor
April 26th 2023
Podcast
Opus Genetics issues 1-month pediatric gene therapy results - Image credit: Adobe Stock / ©Andrii Yalanskyi

Opus Genetics issues 1-month pediatric gene therapy results

Lynda Charters
April 9th 2025
Article
FDA accepts updated BLA from Outlook Therapeutics for ONS-5019 for wet AMD - Image credit: Adobe Stock / ©Have a nice day

FDA accepts updated biologics license application from Outlook Therapeutics for ONS-5010 for the treatment of wet AMD

Martin David Harp, Editor, Ophthalmology Times
April 9th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.